Sandoz Snapshot
Sandoz contributes to society’s ability to support growing healthcare needs by helping people around the world access high-quality medicine. That's our Purpose!
Today Sandoz provides more than 900 million patient treatments to patients across more than 100 countries globally.
Our global portfolio comprises approximately 1 000+ molecules, covering a wide range of therapeutic areas. Our broad offering translates into substantial and ongoing savings for patients and payors, which help to ensure the sustainability of healthcare systems in the face of significant budgetary pressures, while also freeing up funding for innovative medicines.
Our broad portfolio is spearheaded by our global leadership positions in both biosimilars, the “cutting edge” of innovative off-patent medicines, and generic antibiotics, the backbone of global healthcare systems. We also run a variety of targeted corporate responsibility programs.
Today Sandoz provides more than 900 million patient treatments to patients across more than 100 countries globally.
Our global portfolio comprises approximately 1 000+ molecules, covering a wide range of therapeutic areas. Our broad offering translates into substantial and ongoing savings for patients and payors, which help to ensure the sustainability of healthcare systems in the face of significant budgetary pressures, while also freeing up funding for innovative medicines.
Our broad portfolio is spearheaded by our global leadership positions in both biosimilars, the “cutting edge” of innovative off-patent medicines, and generic antibiotics, the backbone of global healthcare systems. We also run a variety of targeted corporate responsibility programs.
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 generating $10.4 bn in sales and while we are proud of this achievement, we have an ambition to do more!
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably.
Sandoz is headquartered in Basel, Switzerland.
With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably.
Sandoz is headquartered in Basel, Switzerland.
Life at Sandoz
Connect with Sandoz
